‹ Screener

OmniAb, Inc.

OABI, OABIW · Services-Commercial Physical & Biological Research · 145.0M shares · +7%/yr ↑ dilution · EDGAR filings ↗

Reference price $1.49 · est. market cap ~$216M — last insider sale, 2026-04-07 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D44

Antibody-discovery licensing platform with deep losses and cash burn, funded.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $4M2025-09-30 · $2M2025-12-31 · $8M2026-03-31 · $14M

Last 4 quarters · from SEC filings.

Key metrics

Operating margin
-369.5%
Net margin
-347.0%
Return on equity
-24.3%
Return on assets
-21.5%
Revenue growth (QoQ)
72.2%
Current ratio
4.0×
Free cash flow
-$37M
EBITDA
-$47M
Tangible book value
$58M
Cash & investments
$54M
Cash runway
6q
Stock comp / revenue
84.8%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-17Gotwals Philip JOption exercise20K
2026-06-17Cochran Jennifer R.Option exercise20K
2026-06-17Crouse Steven C.Option exercise20K
2026-06-17Bertozzi Carolyn ROption exercise20K
2026-06-17Love StevenOption exercise20K
2026-06-17HIGGINS JOHN LOption exercise20K
2026-04-21Crouse Steven C.Option exercise13K
2026-04-21Gotwals Philip JOption exercise13K
2026-04-07GUSTAFSON KURT AOption exercise14K
2026-04-07FOEHR MATTHEW WOption exercise36K
2026-04-07FOEHR MATTHEW WSell19K$1.49
2026-04-07GUSTAFSON KURT ASell6.9K$1.49
2026-04-07Berkman Charles SOption exercise14K
2026-04-07Berkman Charles SSell7.2K$1.49
2026-02-18GUSTAFSON KURT AOption exercise19K
2026-02-18GUSTAFSON KURT ASell9.3K$1.71
2026-02-18Berkman Charles SOption exercise19K
2026-02-18Berkman Charles SSell9.7K$1.71
2026-02-18FOEHR MATTHEW WOption exercise58K
2026-02-18FOEHR MATTHEW WSell31K$1.71
2026-02-17Berkman Charles SSell7.0K$1.70
2026-02-17FOEHR MATTHEW WSell21K$1.70
2026-02-17GUSTAFSON KURT ASell6.8K$1.70
2026-02-16GUSTAFSON KURT AOption exercise14K
2026-02-16FOEHR MATTHEW WOption exercise36K
2026-02-16Berkman Charles SOption exercise14K
2026-01-30HIGGINS JOHN LOption exercise13K
2025-12-08FOEHR MATTHEW WSell14K$1.96
2025-12-08GUSTAFSON KURT ASell24K$1.96
2025-12-08Berkman Charles SSell8.0K$1.96
2025-12-07Berkman Charles SOption exercise16K
2025-12-07GUSTAFSON KURT AOption exercise46K
2025-12-07FOEHR MATTHEW WOption exercise27K
2025-11-07HIGGINS JOHN LBuy41K$1.38
2025-11-06HIGGINS JOHN LBuy36K$1.41
2025-11-01Bertozzi Carolyn ROption exercise18K
2025-11-01Love StevenOption exercise13K
2025-08-26FOEHR MATTHEW WGrant541K$1.85
2025-06-17Cochran Jennifer R.Option exercise20K
2025-06-17Bertozzi Carolyn ROption exercise20K
2025-06-17Love StevenOption exercise20K
2025-06-17HIGGINS JOHN LOption exercise20K
2025-05-15Cochran Jennifer R.Buy30K$1.52
2025-05-14Love StevenBuy25K$1.46
2025-05-12HIGGINS JOHN LBuy65K$1.44
2025-04-07FOEHR MATTHEW WOption exercise36K
2025-04-07FOEHR MATTHEW WSell19K$2.00
2025-04-07Berkman Charles SOption exercise14K
2025-04-07Berkman Charles SSell7.2K$2.00
2025-04-07GUSTAFSON KURT AOption exercise14K
2025-04-07GUSTAFSON KURT ASell7.2K$2.00
2025-04-01GUSTAFSON KURT AOption exercise23K
2025-04-01GUSTAFSON KURT ASell12K$2.37
2025-03-21HIGGINS JOHN LBuy4.0K$2.28
2025-03-20HIGGINS JOHN LBuy126K$2.35
2025-02-19FOEHR MATTHEW WSell20K$3.67
2025-02-19Berkman Charles SSell7.3K$3.67
2025-02-19GUSTAFSON KURT ASell7.3K$3.67
2025-02-18Berkman Charles SSell8.2K$3.68
2025-02-18FOEHR MATTHEW WSell14K$3.68
2025-02-16GUSTAFSON KURT AOption exercise14K
2025-02-16FOEHR MATTHEW WOption exercise36K
2025-02-16Berkman Charles SOption exercise14K
2025-02-15Berkman Charles SOption exercise16K
2025-02-15FOEHR MATTHEW WOption exercise27K
2025-01-30HIGGINS JOHN LOption exercise13K
2025-01-21FOEHR MATTHEW WSell42K$3.24
2025-01-21Berkman Charles SSell25K$3.24
2025-01-21GUSTAFSON KURT ASell16K$3.24
2025-01-17Berkman Charles SGrant45K
2025-01-17FOEHR MATTHEW WGrant77K
2025-01-17GUSTAFSON KURT AGrant28K

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-18Shareholder votefiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-03-04ResultsExhibitsfiling ↗
2026-01-305.03Exhibitsfiling ↗
2025-11-04ResultsExhibitsfiling ↗
2025-08-25Material agreement3.02Reg FDExhibitsfiling ↗
2025-08-06ResultsExhibitsfiling ↗
2025-06-18Shareholder votefiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-182026-06-170001846253-26-000039 ↗
8-K2026-05-072026-05-070001846253-26-000035 ↗
10-Q2026-05-072026-03-310001846253-26-000037 ↗
10-K2026-03-042025-12-310001846253-26-000009 ↗
8-K2026-03-042026-03-040001846253-26-000006 ↗
8-K2026-01-302026-01-300001846253-26-000002 ↗
10-Q2025-11-042025-09-300001628280-25-048923 ↗
8-K2025-11-042025-11-040001628280-25-048850 ↗
8-K2025-08-252025-08-240001193125-25-186981 ↗
10-Q2025-08-062025-06-300001846253-25-000066 ↗
8-K2025-08-062025-08-060001846253-25-000064 ↗
8-K2025-06-182025-06-170001846253-25-000059 ↗